| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M406727200 |
| P698 | PubMed publication ID | 15317813 |
| P2093 | author name string | David Gailani | |
| José A. López | |||
| Frank A. Baglia | |||
| Peter N. Walsh | |||
| P2860 | cites work | Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain | Q24564856 |
| Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation | Q27639267 | ||
| The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface | Q28115496 | ||
| Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential | Q28628884 | ||
| Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains | Q28630112 | ||
| Binding of coagulation factor XI to washed human platelets | Q28630716 | ||
| Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein | Q34186280 | ||
| Factor XI activation in a revised model of blood coagulation | Q34500136 | ||
| The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane | Q38358943 | ||
| Factor XI activation by thrombin and factor XIa. | Q40731412 | ||
| Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein | Q40762400 | ||
| Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX. | Q40912856 | ||
| Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77. | Q42829851 | ||
| Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. | Q43782195 | ||
| Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively | Q45063820 | ||
| A binding site for heparin in the apple 3 domain of factor XI. | Q47954505 | ||
| Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin | Q50335788 | ||
| Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. | Q50335789 | ||
| Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin | Q56765883 | ||
| Defective binding of factor XI-N248 to activated human platelets | Q74064343 | ||
| P433 | issue | 44 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 45470-45476 | |
| P577 | publication date | 2004-08-17 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification of a Binding Site for Glycoprotein Ibα in the Apple 3 Domain of Factor XI | |
| P478 | volume | 279 |
| Q28748458 | A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo |
| Q35126274 | Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor |
| Q35920828 | Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants |
| Q47311661 | An update on factor XI structure and function |
| Q34153581 | Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa |
| Q37739907 | Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go? |
| Q55052361 | Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI. |
| Q37078887 | Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation |
| Q42152415 | Crystal structure of the factor XI zymogen reveals a pathway for transactivation |
| Q24315027 | Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions |
| Q37271059 | Factor XI contributes to thrombin generation in the absence of factor XII |
| Q92053238 | Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present) |
| Q37374500 | Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). |
| Q36169665 | Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI. |
| Q88569228 | Recent advances in the discovery and development of factor XI/XIa inhibitors |
| Q35219258 | Site-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite |
| Q37561457 | Structural and functional features of factor XI. |
| Q34095400 | Structure and function of factor XI |
| Q33943794 | Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket |
| Q34547334 | Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa |
| Q37853060 | The many faces of the contact pathway and their role in thrombosis |
| Q53061821 | Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib |
| Q37318613 | Update on the physiology and pathology of factor IX activation by factor XIa. |
Search more.